HSBC cuts biotech stocks: Eli Lilly lowered to Reduce
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
GSK Q1 earnings preview: 'Vaccines remain a drag' – Barclays
April 29, 2025 4:00 PM EDTBarclays told investors in a note Tuesday that it expects GSK's (NYSE: GSK) first-quarter 2025 results to be weighed down by continued weakness in its vaccines segment, but believes the rest of the portfolio will provide enough support to meet consensus expectations.
Vaccines remain a drag, the analysts wrote, citing ongoing declines in prescriptions for both Shingrix and Arexvy in the U.S.
Barclays trimmed its forecasts for these key vaccines ahead of earnings,... More
